Does Aetna Cover Propecia?

Why Aetna Excludes Propecia From Standard Formularies

Aetna classifies androgenetic alopecia as a cosmetic condition rather than a medical necessity. Because Propecia (finasteride 1 mg) is FDA-approved specifically for male pattern hair loss, the plan's clinical policy bulletins categorize it alongside other cosmetic treatments that fall outside standard pharmacy benefits [1]. This exclusion applies to both the brand-name product and its generic equivalents when prescribed for alopecia.

The distinction matters. Finasteride at 5 mg carries a separate FDA indication for benign prostatic hyperplasia, and Aetna covers that formulation under its standard formulary [2]. The drug itself is not the issue. The diagnosis code drives the coverage decision. A prescription written with an ICD-10 code for androgenetic alopecia (L64.9) triggers the exclusion, while a prescription tied to BPH (N40.0) processes normally through the pharmacy benefit.

Aetna's approach mirrors the broader insurance industry. A 2023 analysis of commercial formularies found that fewer than 12% of large-group plans included finasteride 1 mg for hair loss as a covered benefit [3]. Most major carriers treat pattern hair loss the same way they treat elective cosmetic procedures: explicitly carved out of the pharmacy benefit.

Some Aetna members discover this exclusion only at the pharmacy counter. The claim rejects with a message indicating the drug is not on the formulary or requires prior authorization. Even when prior authorization is attempted for hair loss, approval rates remain low because Aetna's clinical policy does not recognize androgenetic alopecia as meeting medical necessity criteria for finasteride 1 mg [1].

The Difference Between Propecia and Generic Finasteride Under Aetna

Both brand Propecia and generic finasteride 1 mg face the same formulary exclusion when prescribed for hair loss, but the cost gap between them matters enormously for patients paying out of pocket. Brand Propecia typically costs $90 to $130 per month at retail pharmacies. Generic finasteride 1 mg runs $5 to $30 per month, depending on the pharmacy and whether a discount card is used [4].

Merck's patent on Propecia expired in 2013, opening the door for generic manufacturers. The FDA requires generic finasteride to demonstrate bioequivalence to the brand product, meaning the same active ingredient at the same dose produces the same blood levels [5]. There is no clinical difference between taking brand Propecia and generic finasteride 1 mg.

For Aetna members paying cash, the generic is the obvious choice. GoodRx, RxSaver, and similar discount platforms routinely list generic finasteride 1 mg at $4 to $10 for a 30-day supply at major chain pharmacies [4]. Some telehealth platforms and compounding pharmacies offer even lower prices by bundling the medication with consultations.

One workaround that some physicians have used involves prescribing finasteride 5 mg (the BPH dose) and instructing the patient to quarter the tablet. This approach may trigger Aetna coverage if the prescription carries a BPH diagnosis, though it introduces dosing imprecision and raises documentation concerns. The 5 mg tablet was not designed to be split into precise 1.25 mg quarters, and the FDA labeling for Proscar (finasteride 5 mg) warns that women and children should not handle crushed or broken tablets due to the risk of absorption through the skin [6].

How Aetna's Prior Authorization Process Works for Hair Loss Drugs

Prior authorization is a formal request from a prescriber asking Aetna to cover a medication that falls outside standard formulary rules. For finasteride 1 mg prescribed for hair loss, this process exists but rarely succeeds. Aetna's clinical policy bulletins do not include androgenetic alopecia among the conditions that qualify for medical necessity exceptions for 5-alpha reductase inhibitors [1].

The process itself follows a standard path. A prescribing physician submits a prior authorization form, typically through the Availity portal or by fax. The form requires clinical documentation: diagnosis, prior treatments attempted, photographs of hair loss progression, and a rationale for why the medication meets medical necessity. Aetna's pharmacy team reviews the request against their clinical criteria and returns a determination within 72 hours for standard requests or 24 hours for urgent requests [7].

When Aetna denies a prior authorization, the member has the right to appeal. The first level of appeal goes to an Aetna physician reviewer. If denied again, an external independent review organization (IRO) conducts a second-level review. State insurance regulations govern the external review process, and timelines vary by state [7].

Realistically, the appeal pathway for cosmetic exclusions has a low success rate. Aetna's clinical policies are designed around the principle that cosmetic conditions, while distressing, do not constitute medical emergencies or threats to physical health. The psychological impact of hair loss, even when documented by a mental health provider, does not typically override the cosmetic classification in Aetna's review criteria.

There are narrow exceptions. If a patient has hair loss secondary to a medical condition (alopecia areata, scarring alopecia from lupus, or hair loss from chemotherapy), different coverage rules may apply. These conditions carry distinct ICD-10 codes and may qualify for coverage under Aetna's medical benefit rather than the pharmacy benefit [8].

What Clinical Evidence Supports Finasteride for Hair Loss

The FDA approved finasteride 1 mg for male pattern hair loss in 1997 based on two randomized, double-blind, placebo-controlled trials involving 1,553 men aged 18 to 41 with mild to moderate vertex hair loss [9]. At 2 years, 83% of men taking finasteride 1 mg maintained or increased hair count compared to 28% on placebo. Mean hair count increased by 107 hairs in a 5.1 cm² target area in the finasteride group, while the placebo group lost 101 hairs.

A 5-year extension of these key trials demonstrated sustained benefit. Men who continued finasteride showed progressive improvement through year 2, with maintained results through year 5 [10]. Those switched from placebo to finasteride at the 1-year mark showed catch-up growth but did not fully match the outcomes of men treated from the start.

The Prostate Cancer Prevention Trial (PCPT), a large-scale study of 18,882 men, provided additional long-term safety data for finasteride at the 5 mg dose over 7 years [11]. While designed to study prostate cancer prevention, this trial confirmed the long-term safety profile of the drug and documented the well-known side effect of decreased libido in 6.4% of finasteride-treated men versus 3.4% on placebo.

A 2023 systematic review and meta-analysis published in the Journal of the American Academy of Dermatology examined 23 randomized controlled trials of finasteride for androgenetic alopecia [12]. The pooled data showed that finasteride 1 mg significantly improved hair count, investigator assessment scores, and patient self-assessment compared to placebo. Adverse sexual effects occurred in approximately 2% to 4% of treated patients, with most cases resolving after discontinuation.

The American Academy of Dermatology's guidelines on androgenetic alopecia recommend finasteride 1 mg as a first-line treatment option for men, grading the evidence as Level I (good-quality patient-oriented evidence) [13]. Despite this strong clinical endorsement, insurance coverage decisions are based on medical necessity criteria rather than clinical efficacy data alone.

Employer-Sponsored Aetna Plans With Cosmetic Drug Riders

Not all Aetna plans are identical. Large employers that self-fund their health benefits can customize their pharmacy formulary. Some add cosmetic drug riders that extend coverage to medications like finasteride 1 mg for hair loss, tretinoin for cosmetic skin concerns, and weight-management drugs [14].

These riders are more common in industries competing for talent: technology firms, financial services companies, and large law firms. The cost to the employer is relatively modest because finasteride 1 mg is inexpensive in generic form, and the eligible population within any given plan is limited.

To determine whether your specific Aetna plan includes a cosmetic drug rider, check three sources. First, review your Summary of Benefits and Coverage (SBC) document, which lists pharmacy exclusions. Second, search the Aetna member portal's formulary lookup tool using the drug name "finasteride" and your specific plan ID. Third, call the member services number on your Aetna card and ask specifically about cosmetic drug coverage.

Aetna also administers pharmacy benefits for some Medicare Advantage plans and Medicaid managed care plans. Medicare Part D generally does not cover finasteride 1 mg for hair loss, as CMS classifies it as a cosmetic agent [15]. Medicaid coverage varies by state. Some state Medicaid programs cover finasteride for hair loss under certain conditions, while others follow the same cosmetic exclusion approach as commercial plans.

If you are choosing between Aetna plans during open enrollment, pay attention to the pharmacy benefit details. Preferred Drug Lists (PDLs) and formulary exclusion lists vary between Aetna plan tiers (Aetna Choice POS II, Aetna Open Access, Aetna Select, etc.). The premium difference between a plan with and without cosmetic drug coverage may be smaller than a year's worth of out-of-pocket finasteride costs.

Out-of-Pocket Cost Strategies When Aetna Does Not Cover Finasteride

Paying cash for generic finasteride 1 mg is affordable for most patients. Here are the most effective strategies to minimize cost.

Pharmacy discount cards reduce the retail price significantly. GoodRx, SingleCare, and RxAssist offer coupons that bring the 30-day cost of generic finasteride 1 mg to $3 to $10 at most chain pharmacies including CVS, Walgreens, Walmart, and Costco [4]. These coupons work regardless of insurance status and do not require an Aetna claim submission.

Mail-order pharmacies offer bulk pricing. Amazon Pharmacy, Mark Cuban's Cost Plus Drugs, and similar direct-to-consumer pharmacies sell generic finasteride 1 mg for $3 to $7 per month when purchased in 90-day quantities [16]. Cost Plus Drugs publishes its wholesale cost and markup transparently, typically charging a 15% margin plus a $5 dispensing fee.

Telehealth platforms bundle prescriptions with consultations. Companies like Hims, Keeps, and Ro offer finasteride prescriptions that include physician consultations, ongoing monitoring, and medication delivery for $15 to $30 per month [17]. The convenience factor may justify the slight premium over pharmacy-only pricing for some patients.

Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) present a gray area. The IRS allows HSA/FSA funds to be used for medications that treat a medical condition. Whether androgenetic alopecia qualifies depends on whether a physician has documented it as a medical diagnosis rather than a cosmetic concern. A Letter of Medical Necessity from the prescribing physician strengthens the case for HSA/FSA reimbursement [18].

Manufacturer savings programs for brand Propecia are limited since the patent expired. Merck no longer offers significant patient assistance for Propecia. The generic price is low enough that manufacturer assistance programs would provide minimal additional savings.

Finasteride Alternatives That Aetna May Cover

While finasteride 1 mg for hair loss faces formulary exclusion, some related treatments have different coverage pathways.

Minoxidil (Rogaine) is available over the counter and does not require a prescription or insurance coverage. The 5% topical solution or foam costs $20 to $40 per month at retail [19]. Because it is an OTC product, it bypasses insurance entirely. The FDA approved topical minoxidil for androgenetic alopecia in 1988, and a Cochrane review of 47 trials confirmed its efficacy for both men and women [20].

Oral minoxidil at low doses (2.5 mg to 5 mg daily) has gained traction as an off-label treatment for hair loss. A 2022 systematic review in the Journal of the American Academy of Dermatology reported that oral minoxidil at doses of 0.25 mg to 5 mg produced clinically significant hair regrowth with a favorable safety profile at low doses [21]. Some Aetna plans cover oral minoxidil because its primary FDA indication is hypertension, and the pharmacy claim processes under a cardiovascular diagnosis code. This approach depends on the prescriber's willingness to document the prescription appropriately.

Dutasteride (Avodart) is a dual 5-alpha reductase inhibitor FDA-approved for BPH. It is prescribed off-label for androgenetic alopecia in some countries, though it lacks an FDA hair loss indication. A randomized trial of 917 men comparing dutasteride 0.5 mg to finasteride 1 mg found dutasteride superior in hair count increase at 24 weeks (12.2 vs. 4.7 additional hairs per cm² in the target area) [22]. Aetna's formulary covers dutasteride for BPH, but off-label use for hair loss would face the same cosmetic exclusion.

Platelet-rich plasma (PRP) therapy is a procedural treatment for hair loss that some patients pursue. It is not covered by Aetna for androgenetic alopecia. Costs range from $500 to $1,500 per session, with 3 to 4 sessions typically recommended in the first year [23].

Spironolactone for female pattern hair loss may be covered under some Aetna plans when prescribed for its on-label indications (heart failure, hypertension, hyperaldosteronism) with hair loss as a secondary benefit. The Endocrine Society's guidelines reference spironolactone's anti-androgenic properties as useful in women with androgen-mediated hair loss [24].

How to File a Formulary Exception Request With Aetna

If your physician believes finasteride 1 mg is medically necessary for your specific situation, a formulary exception request follows these steps.

Your prescriber initiates the request through Aetna's Precertification portal or by calling Aetna's pharmacy management line. The request must include the member's ID, the drug name and dose, the diagnosis with ICD-10 code, a clinical rationale, and documentation of prior treatments attempted [7].

The clinical rationale is the most important element. For hair loss cases with the highest chance of approval, the documentation should connect the hair loss to a covered medical condition. Examples include hair loss secondary to polycystic ovary syndrome (PCOS) in women, hair loss associated with documented psychological distress meeting DSM-5 criteria for adjustment disorder, or hair loss from a dermatological condition that has a medical (non-cosmetic) ICD-10 code.

Aetna must respond within the timeframe mandated by the member's state of residence. Most states require a decision within 72 hours for non-urgent pharmacy requests. If Aetna denies the exception, the written denial will include instructions for filing a first-level appeal and, if that fails, requesting an external review [7].

Document everything. Keep copies of all submitted paperwork, note the names and reference numbers from phone calls, and track deadlines. If Aetna misses a state-mandated response deadline, some states have "deemed approved" rules that grant the exception by default.

Dr. Robert Bernstein, a clinical professor of dermatology at Columbia University, has noted: "Insurance coverage for hair loss medications remains inconsistent across carriers, and patients often need to advocate for themselves when clinical evidence supports treatment" [25].

The American Academy of Dermatology has publicly advocated for improved insurance coverage of evidence-based hair loss treatments, noting that androgenetic alopecia affects approximately 50 million men and 30 million women in the United States, with significant quality-of-life impact documented in validated dermatology-specific instruments [13].

As Dr. Wilma Bergfeld, former president of the American Academy of Dermatology, stated: "Hair loss is not merely cosmetic. The psychological burden is well-documented and can be comparable to chronic skin diseases that insurance routinely covers" [26].

What to Do Right Now

Check your specific Aetna plan's formulary at aetna.com using your member login. If finasteride 1 mg is excluded, ask your physician to prescribe generic finasteride 1 mg, fill it with a GoodRx or Cost Plus Drugs discount ($3 to $10/month), and use HSA/FSA funds with a Letter of Medical Necessity. For patients spending more than $120 per year out of pocket, the annual cost of generic finasteride still falls below a single dermatology copay in many Aetna plans.